Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pe... (ve to brand drugs.Clearly more of our me...)

Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pennsylvania

Date:12/12/2007

ve to brand drugs. Clearly, more of our members are choosing generic drugs as a sensible way to control their health care costs without sacrificing quality."

"Some members have gone so far as writing us personal notes to say that No Pay Copay helped their families afford needed medications in 2007 and that they will continue to save money by asking for generics," said Frick, adding that IBC offers a wide array of drug plans that make access to generics easy for members.

Generics typically cost up to 70 percent less than the comparable brand name drugs. The lower costs for generic drugs are generally associated with the lower marketing and development costs for those drugs.

The IBC survey was conducted by DSS Research, a leading national health care research and consulting firm headquartered in Fort Worth, Texas. In September, DSS interviewed 805 adult IBC members in the five-county southeastern Pennsylvania area and the surrounding region who were eligible for IBC's No Pay Copay during 2007. The margin of error on the overall sample was +/- 3.5 percent.

Additional Survey Findings

Perception of Generics

No Pay Copay clearly improved members' understanding of and confidence in

generics:

- An encouraging 87 percent of surveyed members said they are likely to

ask for generics after No Pay Copay ends, demonstrating their confidence

in the safety and effectiveness of generics over brand name drugs.

- Forty-four percent of surveyed members said they would not have asked

for generics in the past but have begun to or will ask for generics

after learning more about them through No Pay Copay in 2007.

- More than 70 percent of those surveyed already had a favorable

impression of generics before No Pay Copay. Now, 45 percent claim they

have an even better impression of generics.

Generic Use in Members with Chronic Conditions

Those members who are t
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
6. Generic prostate drug helps find high-risk cancers early
7. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
8. Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
9. FDA Announces Initiative to Bolster Generic Drug Program
10. FDA Struggles to Keep Pace With Requests for Generics
11. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)

Post Your Comments:

Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pe...(ve to brand drugs.Clearly more of our me...),Health